2016_Head & Neck COURSE BOOK

HPV

•638 HN and Esophageal cancer pts - 1599 controls tested for HPV16 E6/7 antibodies on pre-diagnostic plasma sample collected on average 6 years before •34.8% of oropharyngeal cancer pts positive for HPV16 E6 Abs vs 0.6% of controls, • OR: 274 (95%CI 110 – 681)

Kreimer AR, JCO June 13

50